Non-hepatocellular carcinoma spinal metastases

C. Rory Goodwin, Nancy Abu-Bonsrah, Christine Boone, Alejandro Ruiz-Valls, Eric W. Sankey, Rachel Sarabia Estrada, Benjamin D. Elder, Thomas Kosztowski, Daniel M. Sciubba

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Metastases to the spine from non-hepatocellular carcinomas, such as cholangiocarcinoma and angiosarcoma, occur rarely. With improvements in oncologic care, the number of patients diagnosed with metastatic cancer is expected to increase. We performed a systematic review of the literature to assess the clinical presentation, treatment, outcome and survival of patients diagnosed with non-hepatocellular carcinoma spinal metastasis using PubMed, Embase, CINAHL, Cochrane Library and Web of Science. We identified 19 cases of spinal metastases from non-hepatocellular carcinomas that fit our pre-specified criteria. The mean age at presentation was 62.3 years and cholangiocarcinoma was the most common subtype. Patients frequently presented with pain, weakness or paraparesis and at the time of diagnosis, most of them had multi-level involvement of the spine. A majority of patients with spinal metastasis were treated either with radiation or chemotherapy or received no treatment. A minority of the reports included information on survival, which revealed a median survival of 1.5 months following diagnosis of the spinal metastasis. Although there is a paucity of published literature on non-hepatocellular carcinoma spinal metastasis, this systematic review provides descriptive clinical characteristics of these patients.

Original languageEnglish (US)
Pages (from-to)22-27
Number of pages6
JournalJournal of Clinical Neuroscience
Volume27
DOIs
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Neoplasm Metastasis
Carcinoma
Cholangiocarcinoma
Survival
Spine
Library Science
Paraparesis
Hemangiosarcoma
PubMed
Patient Care
Radiation
Drug Therapy
Pain
Neoplasms
Therapeutics

Keywords

  • Angiosarcoma
  • Cholangiocarcinoma
  • Hepatoblastoma
  • Metastasis
  • Non-hepatocellular carcinoma
  • Spine

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Goodwin, C. R., Abu-Bonsrah, N., Boone, C., Ruiz-Valls, A., Sankey, E. W., Sarabia Estrada, R., ... Sciubba, D. M. (2016). Non-hepatocellular carcinoma spinal metastases. Journal of Clinical Neuroscience, 27, 22-27. https://doi.org/10.1016/j.jocn.2015.11.003

Non-hepatocellular carcinoma spinal metastases. / Goodwin, C. Rory; Abu-Bonsrah, Nancy; Boone, Christine; Ruiz-Valls, Alejandro; Sankey, Eric W.; Sarabia Estrada, Rachel; Elder, Benjamin D.; Kosztowski, Thomas; Sciubba, Daniel M.

In: Journal of Clinical Neuroscience, Vol. 27, 01.05.2016, p. 22-27.

Research output: Contribution to journalReview article

Goodwin, CR, Abu-Bonsrah, N, Boone, C, Ruiz-Valls, A, Sankey, EW, Sarabia Estrada, R, Elder, BD, Kosztowski, T & Sciubba, DM 2016, 'Non-hepatocellular carcinoma spinal metastases', Journal of Clinical Neuroscience, vol. 27, pp. 22-27. https://doi.org/10.1016/j.jocn.2015.11.003
Goodwin, C. Rory ; Abu-Bonsrah, Nancy ; Boone, Christine ; Ruiz-Valls, Alejandro ; Sankey, Eric W. ; Sarabia Estrada, Rachel ; Elder, Benjamin D. ; Kosztowski, Thomas ; Sciubba, Daniel M. / Non-hepatocellular carcinoma spinal metastases. In: Journal of Clinical Neuroscience. 2016 ; Vol. 27. pp. 22-27.
@article{9d2ce24fd3d04bd3872e0d55915a7dad,
title = "Non-hepatocellular carcinoma spinal metastases",
abstract = "Metastases to the spine from non-hepatocellular carcinomas, such as cholangiocarcinoma and angiosarcoma, occur rarely. With improvements in oncologic care, the number of patients diagnosed with metastatic cancer is expected to increase. We performed a systematic review of the literature to assess the clinical presentation, treatment, outcome and survival of patients diagnosed with non-hepatocellular carcinoma spinal metastasis using PubMed, Embase, CINAHL, Cochrane Library and Web of Science. We identified 19 cases of spinal metastases from non-hepatocellular carcinomas that fit our pre-specified criteria. The mean age at presentation was 62.3 years and cholangiocarcinoma was the most common subtype. Patients frequently presented with pain, weakness or paraparesis and at the time of diagnosis, most of them had multi-level involvement of the spine. A majority of patients with spinal metastasis were treated either with radiation or chemotherapy or received no treatment. A minority of the reports included information on survival, which revealed a median survival of 1.5 months following diagnosis of the spinal metastasis. Although there is a paucity of published literature on non-hepatocellular carcinoma spinal metastasis, this systematic review provides descriptive clinical characteristics of these patients.",
keywords = "Angiosarcoma, Cholangiocarcinoma, Hepatoblastoma, Metastasis, Non-hepatocellular carcinoma, Spine",
author = "Goodwin, {C. Rory} and Nancy Abu-Bonsrah and Christine Boone and Alejandro Ruiz-Valls and Sankey, {Eric W.} and {Sarabia Estrada}, Rachel and Elder, {Benjamin D.} and Thomas Kosztowski and Sciubba, {Daniel M.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.jocn.2015.11.003",
language = "English (US)",
volume = "27",
pages = "22--27",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Non-hepatocellular carcinoma spinal metastases

AU - Goodwin, C. Rory

AU - Abu-Bonsrah, Nancy

AU - Boone, Christine

AU - Ruiz-Valls, Alejandro

AU - Sankey, Eric W.

AU - Sarabia Estrada, Rachel

AU - Elder, Benjamin D.

AU - Kosztowski, Thomas

AU - Sciubba, Daniel M.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Metastases to the spine from non-hepatocellular carcinomas, such as cholangiocarcinoma and angiosarcoma, occur rarely. With improvements in oncologic care, the number of patients diagnosed with metastatic cancer is expected to increase. We performed a systematic review of the literature to assess the clinical presentation, treatment, outcome and survival of patients diagnosed with non-hepatocellular carcinoma spinal metastasis using PubMed, Embase, CINAHL, Cochrane Library and Web of Science. We identified 19 cases of spinal metastases from non-hepatocellular carcinomas that fit our pre-specified criteria. The mean age at presentation was 62.3 years and cholangiocarcinoma was the most common subtype. Patients frequently presented with pain, weakness or paraparesis and at the time of diagnosis, most of them had multi-level involvement of the spine. A majority of patients with spinal metastasis were treated either with radiation or chemotherapy or received no treatment. A minority of the reports included information on survival, which revealed a median survival of 1.5 months following diagnosis of the spinal metastasis. Although there is a paucity of published literature on non-hepatocellular carcinoma spinal metastasis, this systematic review provides descriptive clinical characteristics of these patients.

AB - Metastases to the spine from non-hepatocellular carcinomas, such as cholangiocarcinoma and angiosarcoma, occur rarely. With improvements in oncologic care, the number of patients diagnosed with metastatic cancer is expected to increase. We performed a systematic review of the literature to assess the clinical presentation, treatment, outcome and survival of patients diagnosed with non-hepatocellular carcinoma spinal metastasis using PubMed, Embase, CINAHL, Cochrane Library and Web of Science. We identified 19 cases of spinal metastases from non-hepatocellular carcinomas that fit our pre-specified criteria. The mean age at presentation was 62.3 years and cholangiocarcinoma was the most common subtype. Patients frequently presented with pain, weakness or paraparesis and at the time of diagnosis, most of them had multi-level involvement of the spine. A majority of patients with spinal metastasis were treated either with radiation or chemotherapy or received no treatment. A minority of the reports included information on survival, which revealed a median survival of 1.5 months following diagnosis of the spinal metastasis. Although there is a paucity of published literature on non-hepatocellular carcinoma spinal metastasis, this systematic review provides descriptive clinical characteristics of these patients.

KW - Angiosarcoma

KW - Cholangiocarcinoma

KW - Hepatoblastoma

KW - Metastasis

KW - Non-hepatocellular carcinoma

KW - Spine

UR - http://www.scopus.com/inward/record.url?scp=84953432597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953432597&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2015.11.003

DO - 10.1016/j.jocn.2015.11.003

M3 - Review article

C2 - 26778049

AN - SCOPUS:84953432597

VL - 27

SP - 22

EP - 27

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -